Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,176.7
-6.2 (-0.20%)

 

  • STI Straits Times Index
    3,176.7
    -6.2 (-0.20%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,492.5
    1.2 (0.08%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,374.6
    -52.0 (-0.20%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,480.4
    3.2 (0.09%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,700.3
    116.2 (0.42%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,197.2
    38.2 (0.62%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 508.7M
  • Value: 615.1M
  • Rise: 136
  • Fall: 140
  • Unch: 483

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
SinoCloud0.001-
Sembcorp Marine0.122-0.001
YZJ Shipbldg SGD1.450+0.020
CPH0.005-0.002
ThaiBev0.665-
Genting Sing0.795-0.005
Keppel Reit1.140+0.020
SPH1.910-0.010
Frencken2.150+0.240
Rex Intl0.240-0.005

World Indices

World Indices
Name Last Change
Nasdaq 14,780.5 +19.2
HSI 26,374.6 -52.0
HSCEI 9,374.0 -45.3
Jakarta 6,202.4 +43.4
Nikkei 225 27,710.2 +126.1
SSE Comp 3,480.4 +3.2
Shanghai A 3,647.8 +3.3
Shanghai B 260.4 +0.4
KOSPI 3,280.8 +0.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

XOMA CORP XOMA CORPORATION
Updated on 04 Aug 2021 (End of trading day)
Last (USD): 30.500 Change: -2.050 High: 33.190 Remarks: -
Change (%): -6.30 Low: 29.270
Open 32.050 Yesterday's Close 32.55
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 24,171 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 0.78024 Trailing EPS (USD) e 0.26993 NAV (USD) b 7.2470
PE a 39.091 Trailing PE f 112.992 Price / NAV b 4.2086
Dividend (USD) d - Cash In Hand (USD) g 6.2070 Issued & Paid-up Shares c 11,269,600
Dividend Yield (%) d - Price / Cash In Hand g 4.914 Treasury Shares h -
Market Cap (M) 343.723 Enterprise Value (M) 293.042
Piotroski F Score 7 Exchange Code XOMA Par Value ( $ ) n.a.
52 Weeks Volatility (%) 58.80 Free Float (%) 93.7
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 10 May 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference XOMA CORP NASDAQ 343.723 39.091 112.992 4.2086 -
Industry Pharmaceuticals: Major NASDAQ 2,400.123 87.799 91.614 8.5150 1.392
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 177,559.561 55.128 46.781 11.3268 2.026
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 126,040.276 8.979 18.201 1.6807 2.681
Local Peer ROYALTY PHARMA PLC NASDAQ 22,305.295 22.876 22.928 4.5687 0.522
Local Peer VIATRIS INC NASDAQ 16,631.162 - - 0.7766 -
Local Peer REPLIGEN CORP NASDAQ 13,886.691 231.730 138.960 8.6626 -
Local Peer CUREVAC NV NASDAQ 10,784.000 - - - -
Local Peer HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS NASDAQ 7,224.001 - - 7.3358 -
Local Peer ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 6,646.774 - - 7.0444 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 6,407.198 - - 31.0333 -
Local Peer I MAB SPON ADS EACH REP 2.3 ORD SHS NASDAQ 5,914.576 86.690 86.690 6.8738 -
Local Peer APELLIS PHARMACEUTICALS INC NASDAQ 5,113.962 - - 99.0026 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 4,578.627 - - 12.3970 -
Other Local Peers IMMUNITYBIO INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), ALLAKOS INC (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), OPKO HEALTH INC (NASDAQ), ERASCA INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), GENERATION BIO CO (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), KRONOS BIO INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), PETIQ INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), GH RESEARCH PLC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), ICOSAVAX INC (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), ESSA PHARMA INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), ANNEXON INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), EVOLUS INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), VERU INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), PHARVARIS NV (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), AC IMMUNE SA (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), CLENE INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), BEYONDSPRING INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), ALZAMEND NEURO INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), 89BIO INC (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), GAMIDA CELL LTD (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), DURECT CORP (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), NEXIMMUNE INC (NASDAQ), HARROW HEALTH INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), MUSTANG BIO INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), IMMUNIC INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), VINCERX PHARMA INC (NASDAQ), OBSEVA SA (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), IMARA INC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), POLYPID LTD (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), GENPREX INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), NOVAN INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), PROPHASE LABS INC (NASDAQ), GALECTO INC (NASDAQ), EYENOVIA INC (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), GRAYBUG VISION INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), ABVC BIOPHARMA INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), BAUDAX BIO INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), PETROS PHARMACEUTICALS INC (NASDAQ), PAINREFORM LTD (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 456,366.733 31.016 25.686 6.5589 2.296
Global Peer PFIZER INC NYSE 252,959.611 26.306 19.123 - 3.367
Global Peer ELI LILLY AND COMPANY NYSE 251,073.815 40.537 41.210 36.3945 1.128
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 222,968.528 27.459 24.790 4.1258 2.105
Global Peer ABBVIE INC NYSE 203,367.074 44.637 30.865 16.1800 4.201
Global Peer MERCK & CO INC NYSE 191,119.889 27.044 34.306 - 3.283
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 174,083.118 27.015 25.896 18.8319 1.370
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 152,192.314 - - 4.1348 2.713
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 101,892.330 13.821 17.179 4.7966 5.109
Global Peer WUXI APPTEC HKEx 526,736.328 158.706 110.568 12.5833 0.197
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMA (HKEx), CANSINOBIO-B (HKEx), INNOVENT BIO (HKEx), SINOPHARM (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), HUTCHMED (HKEx), ORGANON & CO (NYSE), HYGEIA HEALTH (HKEx), REMEGEN-B (HKEx), JUNSHI BIO (HKEx), SH PHARMA (HKEx), AKESO-B (HKEx), CMS (HKEx), INNOCARE-B (HKEx), BAIYUNSHAN PH (HKEx), CHINARES PHARMA (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), TRAD CHI MED (HKEx), SIMCERE PHARMA (HKEx), CHINAGRANDPHARM (HKEx), EVEREST MED-B (HKEx), HENLIUS (HKEx), CSTONE PHARMA-B (HKEx), CARSGEN-B (HKEx), HEPALINK (HKEx), SSY GROUP (HKEx), OCUMENSION-B (HKEx), ADC THERAPEUTICS SA (NYSE), AMNEAL PHARMACEUTICALS INC (NYSE), ZYMEWORKS INC (NYSE), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), UNITED LAB (HKEx), ANTENGENE-B (HKEx), TONGRENTANGCM (HKEx), IMMUNOTECH-B (HKEx), Kimia Farma Tbk. (IDX), SCICLONE PHARMA (HKEx), CKLIFE SCIENCES (HKEx), SHINEWAY PHARM (HKEx), ZHAOKE OPHTH-B (HKEx), HUA MEDICINE-B (HKEx), Soho Global Health Tbk. (IDX), IGBB (Bursa), STARPHARMA HOLDINGS LIMITED (ASX), RACE ONCOLOGY LTD (ASX), PYC THERAPEUTICS LIMITED (ASX), AFT PHARMACEUTICALS LTD (ASX), DAWNRAYS PHARMA (HKEx), TOT BIOPHARM-B (HKEx), ANNOVIS BIO INC (NYSE American), BSTEAD (Bursa), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), PHARMA (Bursa), FUSEN PHARM (HKEx), LANNETT CO INC (NYSE), IP (SET), CH BIOTECH SER (HKEx), ZHONGZHIPHARM (HKEx), IX Biopharma (SGX), NOXOPHARM LTD (ASX), RECCE PHARMACEUTICALS LTD (ASX), Merck Tbk. (IDX), CRESO PHARMA LTD (ASX), NEW RAY MEDIC (HKEx), CHARMACY PHAR (HKEx), KOTRA (Bursa), NC HEALTHCARE (HKEx), PAK FAH YEOW (HKEx), Phapros Tbk. (IDX), Hyphens Pharma (SGX), MODERN CHI MED (HKEx), NOVA (Bursa), INVION LTD (ASX), BIOHLDG (Bursa), EXOPHARM LTD (ASX), NEP INTERLONG (HKEx), AGEX THERAPEUTICS INC (NYSE American), WAI YUEN TONG (HKEx), MEDLAB CLINICAL LIMITED (ASX), PALLA PHARMA LTD (ASX), TBG DIAGNOSTICS LTD (ASX), PURAPHARM (HKEx), EXTRAWELL PHAR (HKEx), TIMBER PHARMACEUTICALS INC (NYSE American), SANAI HEALTH GP (HKEx), PHARMAXIS (ASX), JCT (SET), ONCOSIL MEDICAL LIMITED (ASX), SUNZEN (Bursa), TALI DIGITAL LIMITED (ASX), IMMURON LIMITED (ASX), ACRUX (ASX), SINOLIFE UTD (HKEx), ISLAND PHARMACEUTICALS LTD (ASX), SUDA PHARMACEUTICALS LTD (ASX), PASHUN INT'L (HKEx), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --3.470
-10.21 %
10 Days --2.360
-7.18 %
20 Days --2.830
-8.49 %
Medium Term Return 3 Months --3.750
-10.95 %
6 Months --8.970
-22.73 %
1 Year -+13.810
+82.74 %
Long Term Return 2 Years -+13.990
+84.74 %
3 Years -+11.200
+58.03 %
5 Years -+18.496
+154.08 %
Annualised Return Annualised --
+20.50 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 15.480 - 46.320 Change From 1 Year Low +15.020 % Change From 1 Year Low (%) +97.03
Change From 1 Year High -15.820 % Change From 1 Year High (%) -34.15
2 Years Range 14.140 - 46.320 Change From 2 Years Low +16.360 % Change From 2 Years Low (%) +115.70
Change From 2 Years High -15.820 % Change From 2 Years High (%) -34.15
5 Years Range 3.960 - 46.320 Change From 5 Years Low +26.540 % Change From 5 Years Low (%) +670.20
Change From 5 Years High -15.820 % Change From 5 Years High (%) -34.15
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
04 Aug 2021 32.050 33.190 29.270 30.500 24,171 -
03 Aug 2021 32.380 32.883 31.600 32.550 4,112 -
02 Aug 2021 32.730 33.990 31.600 32.450 9,994 -
30 Jul 2021 31.990 33.990 31.990 32.400 14,318 -
29 Jul 2021 33.810 34.980 32.030 32.210 26,775 -
28 Jul 2021 36.250 37.500 32.570 33.970 44,966 -
27 Jul 2021 32.830 33.990 31.846 33.520 19,763 -
26 Jul 2021 33.280 33.540 32.180 32.830 10,907 -
23 Jul 2021 32.305 33.490 32.305 33.400 5,037 -
22 Jul 2021 32.700 32.860 32.010 32.510 8,382 -
21 Jul 2021 32.730 33.950 32.730 32.860 17,609 -
20 Jul 2021 31.020 33.565 30.060 32.440 35,430 -
19 Jul 2021 31.890 32.760 30.000 30.740 32,293 -
16 Jul 2021 32.850 32.980 31.950 32.590 11,870 -
15 Jul 2021 32.390 33.301 31.273 32.280 15,856 -
14 Jul 2021 32.730 33.320 32.210 32.390 14,286 -
13 Jul 2021 33.350 33.350 32.001 32.840 17,927 -
12 Jul 2021 34.140 34.880 32.930 33.370 13,505 -
09 Jul 2021 35.450 35.450 33.770 34.540 20,126 -
08 Jul 2021 32.820 35.400 32.810 34.790 24,157 -
07 Jul 2021 34.340 34.340 32.510 33.330 28,665 -
06 Jul 2021 33.540 34.710 33.170 34.010 14,378 -
Summary
Current 2 Weeks
(22 Jul 2021 to 04 Aug 2021)
32.700 37.500 29.270 30.500 168,425 -
Previous 2 Weeks
(08 Jul 2021 to 21 Jul 2021)
32.820 37.500 29.270 32.860 203,059 -
4 Weeks from
(09 Jun 2021 to 07 Jul 2021)
29.060 37.500 28.300 33.330 809,900 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Fin